First selective direct mono-arylation of piperidines using ruthenium-catalyzed C–H activation
摘要:
A Ru-catalyzed mono-arylation in alpha-position of saturated cyclic amines is reported employing a C-H activation protocol. Substitution of the pyridine directing group with a bulky group, e.g., trifluoromethyl in the 3-position, proved to be crucial to avoid bis-arylation. This highly selective transformation can be performed with different amines and arylboronate esters. Additionally, the directing group can be cleaved, taking advantage of an unprecedented detrifluoromethylation reaction.
First selective direct mono-arylation of piperidines using ruthenium-catalyzed C–H activation
摘要:
A Ru-catalyzed mono-arylation in alpha-position of saturated cyclic amines is reported employing a C-H activation protocol. Substitution of the pyridine directing group with a bulky group, e.g., trifluoromethyl in the 3-position, proved to be crucial to avoid bis-arylation. This highly selective transformation can be performed with different amines and arylboronate esters. Additionally, the directing group can be cleaved, taking advantage of an unprecedented detrifluoromethylation reaction.
[EN] NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE GLUCOSYLCÉRAMIDASE NON LYSOSOMALE ET LEURS UTILISATIONS
申请人:ALECTOS THERAPEUTICS INC
公开号:WO2020229968A1
公开(公告)日:2020-11-19
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
[EN] NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA GLUCOSYLCÉRAMIDASE NON LYSOSOMALE ET LEURS UTILISATIONS
申请人:ALECTOS THERAPEUTICS INC
公开号:WO2021224865A1
公开(公告)日:2021-11-11
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
[EN] NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE GLUCOSYLCÉRAMIDASES NON LYSOSOMALES ET LEURS UTILISATIONS
申请人:ALECTOS THERAPEUTICS INC
公开号:WO2021224864A1
公开(公告)日:2021-11-11
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
Nucleophilic displacement in 2-chloro(trifluoromethyl)pyridines with amines and ammonia
作者:A.D Dunn
DOI:10.1016/s0022-1139(98)00308-x
日期:1999.2
The activating effect of trifluoromethyl groups in 2-chloro(trifluoromethyl)pyridines was investigated by comparing reactions of these compounds and of 2-chloropyridine with secondary cyclic amines. The ammonolysis of 2-chloro-3-trifluoromethylpyridine and 2-chloro-4-trifluoromethylpyridine is also reported and shown to proceed, in contrast to the reported behaviour of 2-chloro-5-trifluoromethylpyridine, without hydrolysis of the trifluoromethyl function. Both 2-amino-3-trifluoromethylpyridine and 2-amino-4-trifluoromethylpyridine were converted (via the corresponding pyridones) to 3-trifluoromethylpyridin-2(1H)-thione and 4-trifluoromethylpyridin-2(1H)-thione, and a number of S-alkyl derivatives of the latter compounds were prepared. (C) 1999 Elsevier Science S.A. All rights reserved.
First selective direct mono-arylation of piperidines using ruthenium-catalyzed C–H activation
作者:Maria C. Schwarz、Navid Dastbaravardeh、Karl Kirchner、Michael Schnürch、Marko D. Mihovilovic
DOI:10.1007/s00706-013-0947-1
日期:2013.4
A Ru-catalyzed mono-arylation in alpha-position of saturated cyclic amines is reported employing a C-H activation protocol. Substitution of the pyridine directing group with a bulky group, e.g., trifluoromethyl in the 3-position, proved to be crucial to avoid bis-arylation. This highly selective transformation can be performed with different amines and arylboronate esters. Additionally, the directing group can be cleaved, taking advantage of an unprecedented detrifluoromethylation reaction.